CBD
CRN: New FDA Announcement on CBD Signals Continued Agency Inaction
In response to a notice issued on Jan. 8, 2021, from the U.S. Food and Drug Administration (FDA), titled, “Better Data for a Better Understanding of the Use and Safety Profile of Cannabidiol (CBD) Products,” the Council for Responsible Nutrition (CRN) issued the following statement: “Today’s notice, late in the day, late in a week that ...
Quality is as Quality Does
Re-examining dietary supplement ingredient quality in a supply-disrupted world. Our expert panel: Daniel Fabricant, PhD, President and CEO, Natural Products Association (NPA), Washington, D.C., www.npanational.org Salma Fathalla, Director, Quality Assurance, Nutrition21, Purchase, NY, https://nutrition21.com Dan Lifton, President, Maypro Ventures, Purchase, NY, www.maypro.com Vishal Shah, Director, Nutriventia, Mumbai, India, https://nutriventia.com William Sommer, Vice President Global Development ...
Iowa Becomes Latest State to Propose CBD Regs
As the U.S. Food and Drug Administration (FDA) continues to defy mounting requests from the U.S. Congress and the natural products industry to provide science-based and public health regulations for CBD, more states are rushing in to fill the vacuum. Iowa recently became the latest state to propose new state regulations for consumable hemp and CBD products. “This is an opportunity for ...
Beyond CBD? Denver-based company aims to forge a new path forward with CBN
Nutrition Industry Executive (NIE) magazine spoke with Charlotte Mosher, director of sales and marketing for Slumber CBN, which is located in Denver, CO (https://slumbercbn.com): NIE: Why is CBN important as an ingredient, and how are you differentiating it, products, and market-wise, from CBD and full-spectrum hemp extracts? CBN is a minor cannabinoid that has been ...
Hemp Lights Up the Natural Products Industry
Despite a smoky regulatory landscape for CBD and hemp-derived products, the power of this $4.7 billion-dollar market alone may mandate a clearer future. Our expert CBD panel: Zora De Grandpre, ND, Physician, Leafreport, Tel Aviv, Israel, www.leafreport.com Alice Hirschel, PhD, Technical Service Director, ABITEC, Columbus, OH, www.abiteccorp.com Collette Kakuk, Vice President of Global Marketing, HempRise, ...
FDA Fails to Deliver Congressionally Mandated Report on CBD Regulations
The U.S. Food and Drug Administration (FDA) failed to meet its deadline to provide a Congressionally mandated report on how it plans to regulate CBD. Congress instructed the FDA in last year’s spending bill to adopt an enforcement discretion policy within 120 days and provide an update of its progress after 60 days. The agency’s first report ...
CRN Applauds U.K. Food Standards Agency for Clear Path Forward for CBD
On Feb. 13, the U.K. Food Standards Agency (FSA) announced it has set a deadline for CBD authentication. FSA is giving the CBD industry a deadline of March 31, 2021 to submit valid novel food authorization applications. After the deadline, only products which have submitted a valid application will be allowed to remain on the market. The ...
NJ Lawmakers Propose Access to Financial Services for CBD Companies
Companies producing and selling hemp-derived CBD products would have access to essential banking services under new legislation introduced yesterday in the New Jersey State Senate. The legislation, introduced by State Sen. Robert W. Singer (R-NJ-30), would clarify that banks and credit unions will not be penalized by state regulators for working with legitimate hemp businesses. The ...
ChromaDex Launches New Line of High Purity CBD Reference Standards
ChromaDex Corp. (Los Angeles, CA) has announced the expansion of its industry-leading reference standards business with a new line of cannabinoid (CBD) reference standards available to researchers across the globe. These new materials are for laboratory use only, not for human consumption. “In the CBD space, we see an abundance of misinformation and a dearth of ...
Senate Confirms Hahn as FDA Commissioner
In a 72-18 Senate vote, Stephen Hahn, MD, FASTRO was confirmed as the new head of the U.S. Food and Drug Administration (FDA), taking charge at a regulatory agency that oversees products ranging from complex cancer drugs, to food, cosmetics, tobacco and CBD. “We look forward to working with Dr. Hahn and his staff to ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
